These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21698355)

  • 21. The Role of lncRNAs in the Stem Phenotype of Pancreatic Ductal Adenocarcinoma.
    Melendez-Zajgla J; Maldonado V
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.
    Penchev VR; Chang YT; Begum A; Ewachiw T; Gocke C; Li J; McMillan RH; Wang Q; Anders R; Marchionni L; Maitra A; Uren A; Rasheed Z; Matsui W
    Mol Cancer Res; 2019 Apr; 17(4):929-936. PubMed ID: 30655325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer stem cells: new understanding of tumorigenesis, clinical implications.
    Ischenko I; Seeliger H; Kleespies A; Angele MK; Eichhorn ME; Jauch KW; Bruns CJ
    Langenbecks Arch Surg; 2010 Jan; 395(1):1-10. PubMed ID: 19421768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.
    Zhou P; Li B; Liu F; Zhang M; Wang Q; Liu Y; Yao Y; Li D
    Mol Cancer; 2017 Feb; 16(1):52. PubMed ID: 28245823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells.
    Dalla Pozza E; Dando I; Biondani G; Brandi J; Costanzo C; Zoratti E; Fassan M; Boschi F; Melisi D; Cecconi D; Scupoli MT; Scarpa A; Palmieri M
    Int J Oncol; 2015 Mar; 46(3):1099-108. PubMed ID: 25502497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Finding and killing the CRABs of pancreatic cancer.
    Caldwell ME; Tuveson DA
    Gastroenterology; 2009 Sep; 137(3):782-5. PubMed ID: 19643193
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of PRDM14 expression in pancreatic cancer suppresses cancer stem-like properties and liver metastasis in mice.
    Moriya C; Taniguchi H; Miyata K; Nishiyama N; Kataoka K; Imai K
    Carcinogenesis; 2017 Jun; 38(6):638-648. PubMed ID: 28498896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of glycoprotein markers for pancreatic cancer CD24+CD44+ stem-like cells using nano-LC-MS/MS and tissue microarray.
    Zhu J; He J; Liu Y; Simeone DM; Lubman DM
    J Proteome Res; 2012 Apr; 11(4):2272-81. PubMed ID: 22335271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis.
    Li X; Zhao H; Gu J; Zheng L
    Int J Clin Exp Pathol; 2015; 8(10):12084-92. PubMed ID: 26722393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic cancer stem cells: new insight into a stubborn disease.
    Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
    Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis.
    Mueller MT; Hermann PC; Heeschen C
    Front Biosci (Elite Ed); 2010 Jan; 2(2):602-13. PubMed ID: 20036905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
    Begum A; Ewachiw T; Jung C; Huang A; Norberg KJ; Marchionni L; McMillan R; Penchev V; Rajeshkumar NV; Maitra A; Wood L; Wang C; Wolfgang C; DeJesus-Acosta A; Laheru D; Shapiro IM; Padval M; Pachter JA; Weaver DT; Rasheed ZA; Matsui W
    PLoS One; 2017; 12(7):e0180181. PubMed ID: 28692661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nestin and other putative cancer stem cell markers in pancreatic cancer.
    Matsuda Y; Kure S; Ishiwata T
    Med Mol Morphol; 2012 Jun; 45(2):59-65. PubMed ID: 22718289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metastasis of pancreatic tumors].
    Häberle L; Braren R; Schlitter AM; Esposito I
    Pathologe; 2015 Nov; 36 Suppl 2():176-80. PubMed ID: 26391249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of melanoma stem cells on melanoma metastasis.
    Yin Q; Shi X; Lan S; Jin H; Wu D
    Oncol Lett; 2021 Jul; 22(1):566. PubMed ID: 34113394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
    Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
    Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer stem cells: their role in pancreatic cancer patient outcomes and what is future?
    Habib M; Saif MW
    JOP; 2013 Jul; 14(4):401-4. PubMed ID: 23846937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
    Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological and clinical relevance of stem cells in pancreatic adenocarcinoma.
    Rasheed ZA; Matsui W
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):15-8. PubMed ID: 22320910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.